Mkt Cap$2.16T+1.54%
24h Vol$96.88B
BTC Dom55.7%
ETH Dom8.8%
F&G13Extreme Fear
BTC$60,022.00+1.35% ETH$1,578.43+1.27% USDT$0.99860.00% BNB$566.32+2.52% USDC$0.9997+0.00% XRP$1.05+1.67% SOL$72.62+10.30% TRX$0.319-1.17% FIGR_HELOC$1.03+0.33% HYPE$64.98+5.86% DOGE$0.0753+2.84% RAIN$0.0157-0.32% USDS$0.9995-0.02% LEO$9.28-0.81% ZEC$423.13+6.32% XLM$0.1786+1.43% BTC$60,022.00+1.35% ETH$1,578.43+1.27% USDT$0.99860.00% BNB$566.32+2.52% USDC$0.9997+0.00% XRP$1.05+1.67% SOL$72.62+10.30% TRX$0.319-1.17% FIGR_HELOC$1.03+0.33% HYPE$64.98+5.86% DOGE$0.0753+2.84% RAIN$0.0157-0.32% USDS$0.9995-0.02% LEO$9.28-0.81% ZEC$423.13+6.32% XLM$0.1786+1.43%
News

stocks

Total Stories
2,511
Section
stocks
Abbott (NYSE: ABT) Surpasses Q1 Expectations with $10 Billion in Sales, $0.98 EPS
Earnings

Abbott (ABT) Beats Q1 Expectations with $10 Billion in Sales, $0.98 EPS

Abbott has reported a strong start to the year with sales reaching $10.0 billion in Q1, driven by a 10.8 percent increase in organic sales growth.

Tim FriesApr 17, 20242 min read